# NATCO Pharma Limited - Inspection Records

Source: https://www.keypedia.com/companies/natco-pharma-limited/4c97e2d8-0023-4572-966f-d396e8fecc05

> Inspection records and compliance data for NATCO Pharma Limited in Rangareddy, None. Access full analysis and detailed observations.

---

## Details

- Name: NATCO Pharma Limited
- FEI Number: 3004540906
- City: Rangareddy
- State: None
- Country Name: India
- Address Line 1: Pharma Division, Kothur Village
- Zip Code: None
- Facility Type: Manufacturer
- Business Operations: FDF MANUFACTURE

## Related Documents

- [483 - NATCO Pharma Limited - 2025-06-19](https://www.keypedia.com/records/483/natco-pharma-limited/f7f3273d-2be6-4f68-9f8f-a170de0e988e) — source: FDA, date: June 19, 2025
- [FDA Inspection 1273711 - NATCO Pharma Limited - 2025-06-19](https://www.keypedia.com/records/fda_inspections/natco-pharma-limited/80aae95c-db8b-4043-b5c3-41597f602f4d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 19, 2025
- [483 - NATCO Pharma Limited - 2023-10-18](https://www.keypedia.com/records/483/natco-pharma-limited/10dc5409-7a8f-438a-84ec-a39ae77c0ab3) — source: FDA, date: October 18, 2023
- [483 - NATCO Pharma Limited - 2023-10-18](https://www.keypedia.com/records/483/natco-pharma-limited/692230d1-0594-4320-ba99-2ef453417bd4) — source: FDA, date: October 18, 2023
- [FDA Inspection 1137171 - NATCO Pharma Limited - 2019-06-24](https://www.keypedia.com/records/fda_inspections/natco-pharma-limited/9c7b0cce-1acc-45b6-a00d-602bb1633ccd) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 24, 2019
- [FDA Inspection 1095772 - NATCO Pharma Limited - 2019-06-06](https://www.keypedia.com/records/fda_inspections/natco-pharma-limited/ea855f48-56a5-4020-95b4-2e58b1a8caf2) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 6, 2019
- [483 - NATCO Pharma Limited - 2019-06-05](https://www.keypedia.com/records/483/natco-pharma-limited/0bf5ef08-8bd5-4fcd-a591-64b19920b76d) — source: FDA, date: June 5, 2019
- [483 - NATCO Pharma Limited - 2017-01-24](https://www.keypedia.com/records/483/natco-pharma-limited/2a205475-5923-4695-9193-3ade2ddbebb2) — source: FDA, date: January 24, 2017
- [FDA Inspection 1011854 - NATCO Pharma Limited - 2017-01-24](https://www.keypedia.com/records/fda_inspections/natco-pharma-limited/6e9d6dc9-1872-4792-aa61-4d0ea396c351) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 24, 2017
- [FDA Inspection 880454 - NATCO Pharma Limited - 2014-05-23](https://www.keypedia.com/records/fda_inspections/natco-pharma-limited/abd681f2-ce54-4551-8971-47c1474bc884) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 23, 2014
- [FDA Inspection 762119 - NATCO Pharma Limited - 2011-11-18](https://www.keypedia.com/records/fda_inspections/natco-pharma-limited/57a12f0b-492e-4d21-af3a-fbf3b3e5ae79) — classification: No Action Indicated (NAI), source: FDA, date: November 18, 2011
- [FDA Inspection 569301 - NATCO Pharma Limited - 2009-02-12](https://www.keypedia.com/records/fda_inspections/natco-pharma-limited/3e086749-4111-4243-a02c-696e249d0123) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 12, 2009

## Related Companies

- [Ipca Laboratories Limited](https://www.keypedia.com/companies/ipca-laboratories-limited/8357cd13-53b4-4e4d-a2a5-54b750096c7a)
- [Dendreon Pharmaceuticals LLC](https://www.keypedia.com/companies/dendreon-pharmaceuticals-llc/3de4a8e5-8e34-4212-8862-ecd5256c6ffe)
- [Nephron Sc Inc](https://www.keypedia.com/companies/nephron-sc-inc/2dadfd52-37b7-4da6-9885-864d470c1b18)
- [Glenmark Pharmaceuticals Limited](https://www.keypedia.com/companies/glenmark-pharmaceuticals-limited/8a329d32-4a7d-4062-8336-1a4c9455759e)
- [Charles River Laboratories Inc](https://www.keypedia.com/companies/charles-river-laboratories-inc/876b68d9-6285-4039-8732-05f876b5d911)
- [Seqirus Inc](https://www.keypedia.com/companies/seqirus-inc/0debebe6-6f57-40d3-abf9-5914fb18b58a)
- [TOLMAR, Inc.](https://www.keypedia.com/companies/tolmar-inc/a73dea00-baea-4f0e-8234-c0becc61322e)
- [Mylan Laboratories Limited](https://www.keypedia.com/companies/mylan-laboratories-limited/b7da9cbd-d5e3-417f-a485-f9e38852b256)
- [Laboratorio Reig Jofre S.A.](https://www.keypedia.com/companies/laboratorio-reig-jofre-sa/a6b83a70-2bd5-4cc1-8007-61357916a14f)
- [Oxalis Labs](https://www.keypedia.com/companies/oxalis-labs/bc19741c-c2c0-43bc-80ad-91eda4acf921)

## Related Officers

- [Consumer Safety Officer ](https://www.keypedia.com/people/anastasia-m-shields/a22b8d52-e3f9-4e61-aa3f-6f03ff2f59df)
- [SVP Consulting & Operations](https://www.keypedia.com/people/linda-f-murphy/a8b9737f-d5f4-4a36-8684-2fb050d008f2)
- [Investigator](https://www.keypedia.com/people/marcellinus-d-dordunoo/a0e35c24-0cf5-4b11-95ba-1693fa3ecb3a)
- [Patric C. Klotzbuecher](https://www.keypedia.com/people/patric-c-klotzbuecher/cbb2e6b5-b001-457e-9073-33535f02926e)
- [Saleem A. Akhtar](https://www.keypedia.com/people/saleem-a-akhtar/1ea49212-bea5-4d43-bd0a-cdede4d3b1cf)
- [Pratik S. Upadhyay](https://www.keypedia.com/people/pratik-s-upadhyay/22ff2e0b-17d4-4c91-a3f0-c7e30b7a115b)